Gene therapies present a unique opportunity to change the way we treat diseases. Given the complex nature of these transformative therapies, it is critical that our regulatory pathways and reimbursement systems are updated to ensure gene therapies are accessible to patients with unmet medical needs. IGT created a new educational resource for regulators and policymakers to help break down the science behind these therapies and demonstrate what it takes to bring them to market. Learn more HERE.
Comments